A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)

Clinical trial NCT00617890 · TERMINATED

Trial details

NCT number: NCT00617890
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteosarcoma Sarcoma, Ewing's Peripheral Neuroectodermal Tumor

Start date: 2008-02-01
Primary completion: 2011-08-31
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.